Norris Medicines Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.48 | 2.77 | 1.11 |
| Operating Expense | 1.56 | 2.65 | 1.13 |
| Net Profit | -0.31 | -0.23 | -0.28 |
| Net Profit Margin | -20.95 | -8.30 | -25.23 |
| Earning Per Share | -0.31 | -0.23 | -0.28 |
| EBIDTA | -0.08 | 0.06 | -0.03 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1.48 |
| Operating Expense | 1.56 |
| Net Profit | -0.31 |
| Net Profit Margin | -20.95 |
| Earning Per Share | -0.31 |
| EBIDTA | -0.08 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 5.82 | 5.64 | 8.36 |
| Operating Expenses Annual | 6.08 | 5.82 | 7.44 |
| Operating Profit Annual | -0.20 | -0.16 | 0.94 |
| Interest Annual | 0.44 | 0.37 | 1.50 |
| Depreciation | 0.54 | 0.57 | 0.63 |
| Net Profit Annual | -1.24 | -1.19 | -1.75 |
| Tax Annual | 0.06 | 0.09 | 0.56 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 5.82 |
| Operating Expenses Annual | 6.08 |
| Operating Profit Annual | -0.20 |
| Interest Annual | 0.44 |
| Depreciation | 0.54 |
| Net Profit Annual | -1.24 |
| Tax Annual | 0.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.04 | 0.02 | 0.02 |
| Cash Flow from Operations | 0.51 | 0.17 | 1.20 |
| Cash Flow from Investing | TBA | 0.05 | -0.02 |
| Cash Flow from Financing | -0.50 | -0.20 | -1.18 |
| Cash Flow at the End | 0.04 | 0.04 | 0.02 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.04 |
| Cash Flow from Operations | 0.51 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | -0.50 |
| Cash Flow at the End | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -3.44 | -2.84 | 11.24 |
| PBIT Margin (%) | -12.71 | -12.94 | 3.71 |
| PBT Margin (%) | 16.16 | 21.99 | 1.20 |
| Net PROFIT Margin (%) | -21.31 | -21.10 | -20.93 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -17.04 | -14.14 | -18.00 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.80 | 0.67 | 0.86 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -3.44 |
| PBIT Margin (%) | -12.71 |
| PBT Margin (%) | 16.16 |
| Net PROFIT Margin (%) | -21.31 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -17.04 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 5.27 | 5.79 | 6.47 |
| Total Current Assets Annual | 6.34 | 6.14 | 4.92 |
| Non Current Assets Annual | 7.47 | 8.04 | 8.77 |
| Total Shareholders Funds Annual | -14.87 | -13.63 | -12.44 |
| Total Assets Annual | 13.81 | 14.19 | 13.69 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 5.27 |
| Total Current Assets Annual | 6.34 |
| Non Current Assets Annual | 7.47 |
| Total Shareholders Funds Annual | -14.87 |
| Total Assets Annual | 13.81 |
No Data Availabe
